Devices descending from K141311
3 later devices reach 0.9% Sodium Chloride Injection, Usp BD Posiflush; SP Syringe, SF Syringe through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +1 | K161552 | 0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe | Becton, Dickinson and Company | 2017 | 2 | 3 |
| +2 | K250884 | 0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe | Becton, Dickinson and Company | 2025 | 0 | — |
| +2 | K213955 | 0.9% Sodium Chloride Injection, USP, BD PosiFlush SafeScrub | Becton, Dickinson and Company | 2022 | 0 | — |